Загрузка...
Belimumab Concentrations in Maternal Serum and Breast Milk During Breastfeeding and the Safety Assessment of the Infant: A Case Study
Background: Belimumab is a recombinant human immunoglobulin G1 lambda monoclonal antibody that binds soluble B lymphocyte stimulator protein with high affinity and inhibits its biological activity. Belimumab is not recommended for breastfeeding women due to insufficient data about its excretion into...
Сохранить в:
| Опубликовано в: : | Breastfeed Med |
|---|---|
| Главные авторы: | , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Mary Ann Liebert, Inc., publishers
2020
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7374635/ https://ncbi.nlm.nih.gov/pubmed/32326740 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1089/bfm.2020.0068 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|